Back
Ovid Therapeutics Vs. Arcutis Biotherapeutics Industry Stock Comparison
Sell
16
OVID
Ovid Therapeutics
Last Price:
1.19
Seasonality Move:
-0.74%
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
9.91
Seasonality Move:
-24.31%
Sell
16
Ovid Therapeutics (OVID)
is a Sell
Is Ovid Therapeutics a Buy, Sell or Hold?
- The current Ovid Therapeutics [OVID] share price is $1.17. The Score for OVID is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- OVID is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy, Sell or Hold?
- The current Arcutis Biotherapeutics [ARQT] share price is $10.14. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OVID Stock Price Chart
What is Ovid Therapeutics's stock price today?
-
The Ovid Therapeutics share price today is $1.17
The current trend is relatively stagnant and OVID is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARQT Stock Price Chart
What is Arcutis Biotherapeutics's stock price today?
-
The Arcutis Biotherapeutics share price today is $10.14
The current trend is moderately bearish and ARQT is experiencing selling pressure, which indicates risk of future bearish movement.
OVID Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 53.54 | Buy |
Chaikin Money Flow: | 92348 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.08 - 1.22) | Buy |
Bollinger Bands (100): | (0.7 - 2.72) | Sell |
ARQT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 49.58 | Sell |
Chaikin Money Flow: | -3424863 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.11 - 10.95) | Buy |
Bollinger Bands (100): | (8.34 - 10.3) | Buy |
OVID Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.13 | Buy |
20-day SMA: | 1.15 | Buy |
50-day SMA: | 1.06 | Buy |
200-day SMA: | 2.51 | Sell |
8-day EMA: | 1.13 | Buy |
20-day EMA: | 1.12 | Buy |
50-day EMA: | 1.22 | Sell |
200-day EMA: | 2.16 | Sell |
ARQT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.45 | Sell |
20-day SMA: | 10.42 | Sell |
50-day SMA: | 9.92 | Buy |
200-day SMA: | 8.19 | Buy |
8-day EMA: | 10.38 | Sell |
20-day EMA: | 10.27 | Sell |
50-day EMA: | 9.92 | Buy |
200-day EMA: | 8.96 | Buy |
Ovid Therapeutics Earnings Growth & OVID Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.23 per share.
Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.
Ovid Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Arcutis Biotherapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |